In this third instalment of the five-part, festive series of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Mark Andrews, investment director of life sciences funds at British Patient Capital (BPC), discussing the vitally hot topic of investment in life sciences.
Key themes from JP Morgan
Prediction is very difficult, especially if it’s about the future
Promoting value-added medicines and renovating old medicines smartly
Digitisation of drug R&D: Avoiding new for novelty’s sake
The problems of animal research for human medicine and the alternatives
The race to develop innovative products and supply chain solutions
The smart-design evolution of the laboratory space
Looking to the future of UK medical device exports
Exploring the reasons behind increasing burdens on clinical research sites
An investor’s perspective on bio and tech
Why digital therapeutics (DTx) are effective and safe, but not being prescribed
AI drug discovery: Where we are and where we’re going
Retaining the human element in healthcare services whilst embracing the potential of robotics
Bringing women’s health up to speed for 21st Century human healthcare
Creating a future where the healthcare ecosystem works for everyone
Key themes from Frontiers Health 2023, with the pharmaphorum team
Reducing the stigma attached to psychedelics
How birth tissue donations are fuelling the cell therapy revolution
Immunometabolism: Providing a new era of targeted medicine
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
Short Wave
Stuff To Blow Your Mind
Unexplainable
All In The Mind